Seiya Tada

493 total citations
14 papers, 411 citations indexed

About

Seiya Tada is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Seiya Tada has authored 14 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Seiya Tada's work include Liver physiology and pathology (7 papers), Fibroblast Growth Factor Research (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Seiya Tada is often cited by papers focused on Liver physiology and pathology (7 papers), Fibroblast Growth Factor Research (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Seiya Tada collaborates with scholars based in Japan and India. Seiya Tada's co-authors include Hiroaki Iwamoto, Rie Sugimoto, Makoto Nakamuta, Munechika Enjoji, Hajime Nawata, Yutaka Nakashima, Masaki Kato, Hironori Sakai, Hajime Nawata and Nobuhiko Higashi and has published in prestigious journals such as Journal of Hepatology, Journal of Gastroenterology and Hepatology and Clinical and Experimental Pharmacology and Physiology.

In The Last Decade

Seiya Tada

13 papers receiving 403 citations

Peers

Seiya Tada
Yvonne Bury United Kingdom
Daniel Karin United States
Lan Wei United States
Tae Jun Park South Korea
Seiya Tada
Citations per year, relative to Seiya Tada Seiya Tada (= 1×) peers Tamara Severi

Countries citing papers authored by Seiya Tada

Since Specialization
Citations

This map shows the geographic impact of Seiya Tada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiya Tada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiya Tada more than expected).

Fields of papers citing papers by Seiya Tada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiya Tada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiya Tada. The network helps show where Seiya Tada may publish in the future.

Co-authorship network of co-authors of Seiya Tada

This figure shows the co-authorship network connecting the top 25 collaborators of Seiya Tada. A scholar is included among the top collaborators of Seiya Tada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiya Tada. Seiya Tada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Tada, Seiya, et al.. (2018). Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Low-risk Myelodysplastic Syndrome by Azacitidine. Internal Medicine. 57(20). 2995–2999. 5 indexed citations
3.
Kohjima, Motoyuki, Kenta Motomura, Toshimasa Koyanagi, et al.. (2016). Therapeutic safety and effectiveness of dual oral therapy with Daclatasvir and Asunaprevir for chronic HCV patients with renal dysfunction. Kanzo. 57(3). 142–145. 2 indexed citations
5.
Nakamuta, Makoto, Satoshi Ohta, Seiya Tada, et al.. (2001). Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. International Journal of Molecular Medicine. 8(5). 553–60. 28 indexed citations
6.
Fukutomi, Takayoshi, Naoko Kinukawa, Seiya Tada, et al.. (2001). Kinetics of the hepatitis C virus during interferon therapy as a marker of therapeutic response. Journal of Gastroenterology and Hepatology. 16(1). 29–33. 5 indexed citations
7.
Tada, Seiya, Munechika Enjoji, Rie Sugimoto, et al.. (2001). Pirfenidone Inhibits Dimethylnitrosamine‐Induced Hepatic Fibrosis In Rats. Clinical and Experimental Pharmacology and Physiology. 28(7). 522–527. 71 indexed citations
8.
Tada, Seiya, Hiroaki Iwamoto, Makoto Nakamuta, et al.. (2001). A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. Journal of Hepatology. 34(4). 529–536. 87 indexed citations
9.
Iwamoto, Hiroaki, Makoto Nakamuta, Seiya Tada, et al.. (2000). A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth. Journal of Hepatology. 32(5). 762–770. 89 indexed citations
10.
Iwamoto, Hiroaki, et al.. (2000). Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth. Journal of Laboratory and Clinical Medicine. 135(5). 406–412. 28 indexed citations
11.
Iwamoto, Hiroaki, Hironori Sakai, Seiya Tada, Makoto Nakamuta, & Hajime Nawata. (1999). Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion. Journal of Laboratory and Clinical Medicine. 134(1). 83–89. 49 indexed citations
12.
Kato, Masaki, Hiroaki Iwamoto, Nobuhiko Higashi, et al.. (1999). Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells. Journal of Hepatology. 31(1). 91–99. 41 indexed citations
13.
Abe, Tetsutaro, et al.. (1989). [Temporal changes in internal echoes in hepatic hemangiomas].. PubMed. 49(5). 574–82. 3 indexed citations
14.
Arimori, S, et al.. (1973). [Pneumomediastinography in patients with hypoplatic anemia].. PubMed. 14(7). 757–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026